First, this study was conducted as an open-label trial.
The non-blinded design could have given room for bias, but meticulous efforts were taken to overcome any potential bias.
The sample size meant that the study was not powered enough to analyze the secondary outcome parameters.
These data come from a single center and cannot be extrapolated to entire ICU populations. Hence further large multicenter trials would be needed.